Skip to content
Screener

Protalix BioTherapeutics, Inc. PLX Q1 2025 earnings

Reported May 9, 2025 · Before market open

Revenue$10.1MMiss by $13.0M
EPS-$0.05Miss by $0.13
Revenue estimate$23.1M
EPS estimate$0.08

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$13.4M
EPS estimate-$0.02

FAQ

When did Protalix BioTherapeutics, Inc. report Q1 2025 earnings?
Protalix BioTherapeutics, Inc. (PLX) reported Q1 2025 earnings on May 9, 2025 before market open.
What were Protalix BioTherapeutics, Inc.'s Q1 2025 revenue and EPS?
Protalix BioTherapeutics, Inc. reported revenue of $10.1M and eps of $-0.05 for Q1 2025.
Did Protalix BioTherapeutics, Inc. beat estimates in Q1 2025?
Revenue missed the consensus estimate of $23.1M by $13.0M. EPS missed the consensus estimate of $0.08 by $0.13.
How did Protalix BioTherapeutics, Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 169.8% from $3.7M a year earlier and eps grew 16.7% from $-0.06.
Where can I find Protalix BioTherapeutics, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0001558370-25-007060) and the 10-Q periodic report (0001558370-25-007063) directly on SEC EDGAR. The filing index links above go to sec.gov.